• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

H. Lundbeck

A shot from Otsuka and Lundbecks  Abilify Asimtufii TV spot
Marketing

Otsuka, Lundbeck start ad push for long-acting bipolar drug

The partners are spreading the message in a multichannel campaign that uses CGI to show how taking Abilify Asimtufii affected a patient’s summer.
Nick Paul Taylor Jun 4, 2024 10:45am
Lundbeck

Lundbeck blames DTC blackout for slowdown in Rexulti growth

May 16, 2024 6:58am
A puzzle of the brain with one missing piece

Mental health patient groups slam pharma over R&D engagement

Sep 26, 2023 7:35am
A screenshot from the Lundbeck and Otsuka ad

Lundbeck, Otsuka run ad to push expanded Alzheimer's label

Jul 28, 2023 10:35am
launch

Pre-launch KOL talks linked to 1.5-time boost to drug uptake

Jul 26, 2023 11:42am
FDA conference hall

FDA accepts Otsuka filing for long-acting schizophrenia drug

Sep 13, 2022 9:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings